Atomera Inc ATOM
Nasdaq · XNAS · stock · Semiconductors & Related Devices
Chart by TradingView
2/9
Piotroski F — financial health
-31.49
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $65,000 | -$20.2M | -$256,000 | -$14.9M | $18.4M |
| 2024 | $135,000 | -$18.4M | $12,000 | -$13.2M | $25.1M |
| 2023 | $550,000 | -$19.8M | $522,000 | -$14.6M | $18.2M |
| 2022 | $382,000 | -$17.4M | $301,000 | -$12.5M | $20.3M |
| 2021 | $400,000 | -$15.7M | $400,000 | -$12.6M | $28.4M |
| 2020 | $62,000 | -$14.9M | $49,000 | -$12.2M | $37.3M |
Why these scores methodology →
Piotroski F-score: 2/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -31.49 (distress)
- Working capital / assets 0.834
- Retained earnings / assets -11.458
- EBIT / assets -1.001
- Equity / liabilities 6.778
Source: SEC EDGAR filings · CIK 0001420520 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.